Centaur Guernsey L.P. Inc. Announces Executive Changes
Aug 25 14
Centaur Guernsey L.P. Inc. announced that Robert Hureau, Executive Vice President and Chief Financial Officer for Centaur and each of its operating subsidiaries Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited, has notified the company that he will be resigning to pursue another career opportunity. Mr. Hureau will continue in his current role until September 23, 2014. Following Mr. Hureau's departure, Brian Busenlehner, Vice President, Corporate Controller, will serve as interim Chief Financial Officer, working closely with President and CEO Joe Woody and the company's senior leadership team on all financial matters. Mr. Busenlehner has served as Vice President, Controller since 2007 and in that role has been responsible for global accounting, financial consolidation and external reporting in addition to providing leadership in support of the company's Global Shared Service Center in Budapest, Hungary.
Centaur Guernsey L.P. Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014
Jul 29 14
Centaur Guernsey L.P. Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported total revenue of $465,171,000 against $432,679,000 a year ago. Operating loss was $140,324,000 against operating profit of $11,131,000 a year ago. Loss from continuing operations before income tax benefit was $242,447,000 against $93,003,000 a year ago. Loss from continuing operations was $152,717,000 against $61,947,000 a year ago. Net loss was $152,717,000 against $62,575,000 a year ago. Adjusted EBITDA from continuing operations was $169,748,000 against $177,015,000 a year ago. Total adjusted EBITDA was $169,748,000 against $177,008,000 a year ago.
For the six months, the company reported total revenue of $574,271,000 against $545,274,000 a year ago. Operating loss was $106,419,000 against operating profit of $46,663,000 a year ago. Loss from continuing operations before income tax benefit was $310,409,000 against $161,342,000 a year ago. Loss from continuing operations was $199,100,000 against $105,318,000 a year ago. Net loss was $199,100,000 against $107,362,000 a year ago. Net cash provided by operating activities was $61,378,000 against $40,393,000 a year ago. Additions to property, plant and equipment was $28,382,000 against $39,981,000 a year ago. Adjusted EBITDA from continuing operations was $324,882,000 against $333,754,000 a year ago. Total adjusted EBITDA was $324,882,000 against $333,744,000 a year ago.